Salivary gland malignant tumor (SGMT) is a malignant disease requiring multidisciplinary approach. The rare incidence and the consequent lack of robust evidence-based medicine has called for a comprehensive update to draw recommendations for clinical practice. This paper is a summary of the XXX Head and Neck Unit guidelines regarding the management of SGMT. Recommendations include the indications for exclusive and adjuvant therapy, as well as metastatic management, for both major and minor SGMT.

Management of salivary gland malignant tumor: the Policlinico Umberto I, "Sapienza" University of Rome Head and Neck Unit clinical recommendations / De Felice, Francesca; de Vincentiis, Marco; Valentini, Valentino; Musio, Daniela; Mezi, Silvia; Lo Mele, Luigi; Della Monaca, Marco; D'Aguanno, Vittorio; Terenzi, Valentina; Di Brino, Martina; Brauner, Edoardo; Bulzonetti, Nadia; Tenore, Gianluca; Pomati, Giulia; Cassoni, Andrea; Tombolini, Mario; Battisti, Andrea; Greco, Antonio; Pompa, Giorgio; Minni, Antonio; Romeo, Umberto; Cortesi, Enrico; Polimeni, Antonella; Tombolini, Vincenzo. - In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. - ISSN 1040-8428. - 120(2017), pp. 93-97. [10.1016/j.critrevonc.2017.10.010]

Management of salivary gland malignant tumor: the Policlinico Umberto I, "Sapienza" University of Rome Head and Neck Unit clinical recommendations

De Felice, Francesca
Primo
;
de Vincentiis, Marco
Secondo
;
Valentini, Valentino;Mezi, Silvia;Lo Mele, Luigi;Della Monaca, Marco;D'Aguanno, Vittorio;Terenzi, Valentina;Di Brino, Martina;Brauner, Edoardo;Tenore, Gianluca;Pomati, Giulia;Cassoni, Andrea;Tombolini, Mario;Battisti, Andrea;Greco, Antonio;Pompa, Giorgio;Minni, Antonio;Romeo, Umberto;Cortesi, Enrico;Polimeni, Antonella
Penultimo
;
Tombolini, Vincenzo
Ultimo
2017

Abstract

Salivary gland malignant tumor (SGMT) is a malignant disease requiring multidisciplinary approach. The rare incidence and the consequent lack of robust evidence-based medicine has called for a comprehensive update to draw recommendations for clinical practice. This paper is a summary of the XXX Head and Neck Unit guidelines regarding the management of SGMT. Recommendations include the indications for exclusive and adjuvant therapy, as well as metastatic management, for both major and minor SGMT.
File allegati a questo prodotto
File Dimensione Formato  
De-Felice_Management_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 162.94 kB
Formato Adobe PDF
162.94 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11573/1070785
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 15
social impact